Anzeige
Mehr »
Montag, 25.08.2025 - Börsentäglich über 12.000 News
Mega-Deal in Kanada: Katapultiert sich diese Aktie jetzt in die Top-Liga der Explorer?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
12.08.Novo Nordisk's Alhemo approved by FDA for expanded haemophilia use
12.08.Biogen/Eisai's Alzheimer's drug Leqembi shows continued benefit over four years
12.08.Embracing uncertainty in precision medicine communications for lung cancer
11.08.FDA unveils PreCheck programme to enhance US domestic pharma supply chain
11.08.Eli Lilly's Mounjaro shown to provide cardiovascular protection in type 2 diabetes patients
11.08.Patient activation: time to think differently about treatments…
08.08.MSD receives NICE recommendation for Keytruda in advanced endometrial cancer
08.08.Novo Nordisk appoints Maziar Mike Doustdar as president and CEO
08.08.Maximising impact in medical communications: where are we now and where are we heading?
07.08.Roche's Evrysdi tablets approved by MHRA to treat spinal muscular atrophy
07.08.Apogee Therapeutics' atopic dermatitis candidate shows promise in phase 2 study
07.08.Empower or fall behind: why true patient engagement is pharma's competitive edge
06.08.AstraZeneca's Imfinzi/Imjudo regimen recommended by NICE to treat liver cancer
06.08.Eli Lilly shares positive results for Jaypirca in head-to-head CLL/SLL study
06.08.Patient activation - not just a strategy but a necessity
05.08.BMS and Bain Capital launch new company to develop immunology therapies
05.08.CHMP recommends BeOne Medicines' Tevimbra for new lung cancer indication
05.08.Solving the patient engagement value equation
04.08.Biogen's Qalsody granted MHRA approval to treat rare form of motor neurone disease
04.08.FDA grants fast track designation to Nektar's rezpegaldesleukin in alopecia areata
04.08.The power of representation, innovation and trust in rare disease clinical trials
01.08.Sanofi's Sarclisa approved by EC to treat newly diagnosed multiple myeloma
01.08.Eli Lilly's Alzheimer's disease drug donanemab recommended by CHMP
01.08.Patient engagement - a journey of health activation
31.07.Merck unveils $3bn cost-cutting plan to support pipeline and new product launches